Clinical Trial Update: BCAA Supplementation for Concussion [Phase 2]

View source ↗

Summary

Phase 2 study evaluating branched-chain amino acid (BCAA) supplementation for concussion completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Concussion

Drugs mentioned

• Branched-chain amino acid (BCAA) supplement (branched-chain amino acids (valine, leucine, isoleucine))

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Brain Concussion | Phase 2 | Status: COMPLETED | Results posted: 2024-05-14